Detalhe da pesquisa
1.
The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment.
Cancer Res
; 80(13): 2903-2913, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409308
2.
Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines.
Oncoimmunology
; 6(3): e1277306, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405498